ARxIUM and Prinses Máxima Centrum Mark More Than One Million Sterile Doses Compounded Using RIVA

Milestone reflects years of collaboration focused on advancing medication quality and supporting complex pediatric oncology care.

BUFFALO GROVE, IL, UNITED STATES, September 21, 2026 /EINPresswire.com/ — Today, ARxIUM^®, Inc., a provider of pharmacy automation and workflow solutions, announced that Prinses Máxima Centrum, the largest pediatric oncology center in Europe, has surpassed one million patient-specific sterile doses compounded using its RIVA^® IV automation platform. The achievement reflects a long-standing collaboration focused on advancing medication quality, operational reliability, and the delivery of specialized care for children with cancer.

As healthcare providers face growing medication complexity, workforce pressures, and increasing expectations for quality and efficiency, pharmacy teams are seeking new ways to strengthen consistency while supporting rising patient demands. Prinses Máxima Centrum’s milestone demonstrates how automation can be incorporated into everyday pharmacy operations to support consistency and increasing patient demands over time.

Over the years, RIVA has become an integral part of Prinses Máxima Centrum’s compounding workflow, helping the pharmacy team manage high volumes of patient-specific preparations while maintaining rigorous standards for accuracy and process control. By reducing reliance on manual steps and creating a more standardized workflow, Prinses Máxima Centrum has been able to support both operational excellence and patient care priorities.

Advancing Pediatric Oncology Pharmacy Care

“Healthcare organizations are being challenged to deliver higher levels of quality, safety, and efficiency while managing increasing operational complexity,” said Nhat H. Ngo, CEO of ARxIUM. “Prinses Máxima Centrum’s achievement illustrates how automation can help pharmacy teams create dependable workflows, support high-quality patient care, and build the operational capacity needed to meet future healthcare demands.”

Since Prinses Máxima Centrum opened its dedicated preparation pharmacy in 2018, two RIVA systems have supported the preparation of sterile medications for pediatric oncology care. The one-million-dose milestone reflects years of automated compounding within a specialized pharmacy environment designed to support both routine sterile preparations and high-risk oncology medications. For pediatric oncology programs where treatment regimens often require individualized therapies, the achievement demonstrates the long-term value of automation in supporting complex medication preparation.

“This milestone reflects the dedication of our pharmacy team and our continued focus on providing high-quality care for every patient,” said Dr. Lidwien Hanff, Director of Pharmacy, Prinses Máxima Centrum. “Through our partnership with ARxIUM, we have established a preparation process that supports the complex treatment schedules required in pediatric oncology while helping our pharmacy team work more efficiently.”

Reaching this milestone demonstrates how a shared commitment to innovation, quality, and patient care can create lasting value for pharmacy teams and the patients they serve.

About ARxIUM

ARxIUM is a global leader in pharmacy automation and workflow solutions, delivering innovative technologies that improve medication safety, operational efficiency, and regulatory compliance across hospital and health system pharmacies. Its comprehensive portfolio spans IV compounding, medication dispensing and packaging, high-volume vial filling, centralized service center solutions, and enterprise software, enabling healthcare organizations to standardize workflows, scale operations, and reduce the total cost of pharmacy operations.

About Prinses Máxima Centrum for pediatric oncology

When a child is seriously ill with cancer, only one thing comes first: a cure.
That is why at the Princess Máxima Center for pediatric oncology, we work together every day in a groundbreaking and passionate way to improve the survival rate and quality of life of children with cancer. Now, and in the longer term. Because children still have a whole life ahead of them.

The Princess Máxima Center is a research hospital, the largest pediatric cancer center in Europe. All children with cancer in the Netherlands are treated here. Our mission: To cure every child with cancer, with optimal quality of life. Over 450 researchers and 900 healthcare professionals work closely with Dutch and international hospitals on better treatments and new perspectives on cures.

In the Princess Máxima Center, Utrecht, Netherlands, the best healthcare professionals and scientists work together on a unique mission: to cure every child with cancer, with optimal quality of life. A mission that remains urgent, as one in four children with cancer dies, and many children who do survive experience the effects of radical treatments throughout their lives.

For more information, visit arxium.com or contact info@arxium.com.

ARxIUM Support
ARxIUM, Inc.
info@arxium.com

Media gallery